Navigation Links
Don't Skip This Year's Flu Shot: CDC
Date:8/18/2011

By Denise Mann
HealthDay Reporter

THURSDAY, Aug. 18 (HealthDay News) -- The 2011-12 flu vaccine protects against seasonal flu and H1N1, just like last year's, but that doesn't mean it's OK to skip your yearly flu shot, researchers from the U.S. Centers for Disease Control and Prevention warn.

"All people aged 6 months and older should be vaccinated," said Dr. Carolyn Bridges, an associate director for adult immunization at the CDC's National Center for Immunization and Respiratory Diseases.

Protection wanes over the course of a year, so "even people who got a flu vaccine last year should get one again to make sure they are optimally protected," she said.

The new recommendations are published in the Aug. 18 issue of the CDC's Morbidity and Mortality Weekly Report.

The fact that the vaccines are identical does change things slightly for children aged 6 months to 8 years. In general, children in this age range should get two doses of the flu shot administered at least four weeks apart, but they will only need one dose of the 2011-2012 vaccine if they received at least one dose in 2010-2011.

Children in that age range who did not get the flu vaccine last year need two doses this season.

The vaccine formulation was recommended by the World Health Organization, and six manufacturers have been chosen to produce and distribute the vaccines for the United States.

The brand names and manufacturers of the vaccines are: Afluria, CSL Limited; Fluarix, GlaxoSmithKline Biologicals; FluLaval, ID Biomedical Corporation; FluMist, MedImmune Vaccines Inc.; Fluvirin, Novartis Vaccines and Diagnostics Limited; and Fluzone, Fluzone High-Dose and Fluzone Intradermal, Sanofi Pasteur Inc.

New this year is an intradermal flu vaccine, Fluzone Intradermal, which will be available for adults aged 18 through 64 years. This vaccine is delivered into the skin, rather than the muscle, using a very small needle, according to the U.S. Food and Drug Administration, which approved it in May.

Last month, the CDC said the targeted flu strains for 2011-2012 are:

  • A/California/7/09 (H1N1)-like virus (pandemic (H1N1) 2009 influenza virus
  • A/Perth/16/2009 (H3N2)-like virus
  • B/Brisbane/60/2008-like virus

Dr. Lisa Grohskopf, an epidemiologist at the CDC's National Center for Immunization and Respiratory Diseases, stressed the importance of getting the 2011-2012 flu vaccine. "If we are looking on an individual basis, we can't tell how quickly antibodies will decay after the vaccine, but we do know that immune response will drop over the course of a year," she said. "You can't count on that vaccine protecting you for a second season."

More information

The U.S. Centers for Disease Control and Prevention has more on the 2011-2012 flu vaccine.

SOURCES: Lisa Grohskopf, M.D., M.P.H., epidemiologist, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta; Carolyn Bridges, M.D., associate director, adult immunization, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention; Aug. 18, 2011, Morbidity and Mortality Weekly Report


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Periodontal pathogens enhance HIV-1 promoter activation in T cells
2. Successful treatment of periodontal disease lowered preterm birth incidences
3. National Prosthodontics Awareness Week Serves and Educates Consumers About Proper Oral Health Care
4. EDS Announces New SafeSiders Endodontic Glide Path Kit
5. Long Island Children's Orthodontist Announces Office Improvements And New Staff Member
6. Researchers study relationship of oral cancers and periodontal disease
7. Successful periodontal therapy may reduce the risk of preterm birth, according to Penn dental study
8. Orthodontic Retainers Can Harbor Harmful Microbes
9. “Hearts and Minds” Education Program Launched: On Average, People with Mental illness Live 25 Years Less than Other Americans
10. The Foundation of the American Academy of Ophthalmology's Museum of Vision Celebrates 30 Years of Preserving Ophthalmic Heritage
11. Material tested that could guarantee body protheses for more than 150 years
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Don't Skip This Year's Flu Shot:  CDC 
(Date:8/18/2017)... ... August 18, 2017 , ... ... LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions ... definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an ... an educational webinar, they will present the line of epMotion automated liquid handling ... easy you can automate everyday pipetting tasks. , Ideal for scientists and lab ...
(Date:8/18/2017)... ... August 18, 2017 , ... Moore Insurance, a Houston ... east Texas, is launching a regional charity effort to provide publicity assistance and ... Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 million in donations that ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Golseth Agency, a Texas based ... area, is spearheading a regional charity campaign organized to provide support to Christina Upchurch ... of this year, Christina and her children returned from out of town to find ...
(Date:8/18/2017)... ... August 18, 2017 , ... Alcovit, a lime-flavored beverage that rids the ... efforts with its product now available through Jet.com. , After 25 years of ... powdered drink is designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 15, 2017 AccuGenomics, Inc., a diagnostic company ... announced that the company has provided an AccuKit to ... Carolina at Chapel Hill and to Qura Therapeutics for ... and quantify HIV reservoir and viral expression in human ... HIV Cure Center is a joint initiative between the ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest ... June 30, 2017.  All comparisons, unless otherwise noted, are to ... Second Quarter 2017 Highlights include: ... an increase of 3.5% Total prescriptions dispensed ... of 7.5% versus 7.6% Gross profit ...
Breaking Medicine Technology: